369 related articles for article (PubMed ID: 33719631)
1. Current Advancements and Novel Strategies in the Treatment of Metastatic Melanoma.
Sood S; Jayachandiran R; Pandey S
Integr Cancer Ther; 2021; 20():1534735421990078. PubMed ID: 33719631
[TBL] [Abstract][Full Text] [Related]
2. Current and future roles of targeted therapy and immunotherapy in advanced melanoma.
Olszanski AJ
J Manag Care Spec Pharm; 2014 Apr; 20(4):346-56. PubMed ID: 24684639
[TBL] [Abstract][Full Text] [Related]
3. Intralesional and systemic immunotherapy for metastatic melanoma.
Luu C; Khushalani NI; Zager JS
Expert Opin Biol Ther; 2016 Dec; 16(12):1491-1499. PubMed ID: 27602429
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapies and melanoma].
Routier É; Robert C; Mateus C
Bull Cancer; 2014 Dec; 101 Suppl 2():S13-24. PubMed ID: 25776763
[TBL] [Abstract][Full Text] [Related]
5. Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.
Marra A; Ferrone CR; Fusciello C; Scognamiglio G; Ferrone S; Pepe S; Perri F; Sabbatino F
Anticancer Agents Med Chem; 2018; 18(2):166-181. PubMed ID: 29256359
[TBL] [Abstract][Full Text] [Related]
6. New drug targets in metastatic melanoma.
Homet B; Ribas A
J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
[TBL] [Abstract][Full Text] [Related]
7. The Emerging Therapeutic Landscape of Advanced Melanoma.
Henriques V; Martins T; Link W; Ferreira BI
Curr Pharm Des; 2018; 24(5):549-558. PubMed ID: 29366407
[TBL] [Abstract][Full Text] [Related]
8. Recent advancements in melanoma management.
Krishnan T; Menzies AM; Roberts-Thomson R
Intern Med J; 2021 Mar; 51(3):327-333. PubMed ID: 33738950
[TBL] [Abstract][Full Text] [Related]
9. [Not Available].
Mateus C; Libenciuc C; Robert C
Bull Cancer; 2016 Jun; 103(6 Suppl 1):S4-S11. PubMed ID: 27494973
[TBL] [Abstract][Full Text] [Related]
10. New developments in the treatment of metastatic melanoma: immune checkpoint inhibitors and targeted therapies.
Azijli K; Stelloo E; Peters GJ; VAN DEN Eertwegh AJ
Anticancer Res; 2014 Apr; 34(4):1493-505. PubMed ID: 24692676
[TBL] [Abstract][Full Text] [Related]
11. A Decade of Success in Melanoma Immunotherapy and Targeted Therapy: What Every Radiologist Should Know.
Chen M; Smith DA; Yoon JG; Vos D; Kikano EG; Tirumani SH; Ramaiya NH
J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):621-632. PubMed ID: 35675685
[TBL] [Abstract][Full Text] [Related]
12. Controversies in the management of advanced melanoma: "gray" areas amid the "black and blue".
Jarkowski A; Norris L; Trinh VA
Ann Pharmacother; 2014 Nov; 48(11):1456-68. PubMed ID: 25056920
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab.
Sachpekidis C; Kopp-Schneider A; Hakim-Meibodi L; Dimitrakopoulou-Strauss A; Hassel JC
Melanoma Res; 2019 Apr; 29(2):178-186. PubMed ID: 30653029
[TBL] [Abstract][Full Text] [Related]
14. Metastatic melanoma.
Sun W; Schuchter LM
Curr Treat Options Oncol; 2001 Jun; 2(3):193-202. PubMed ID: 12057119
[TBL] [Abstract][Full Text] [Related]
15. The Treatment of Advanced Melanoma: Therapeutic Update.
Villani A; Potestio L; Fabbrocini G; Troncone G; Malapelle U; Scalvenzi M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742834
[TBL] [Abstract][Full Text] [Related]
16. New treatments for cutaneous metastatic melanoma: MAPK pathway-targeted and immune based therapies.
Ranchon F; Boespflug A; Rioufol C; Schwiertz V; Thomas L; Dalle S
Anticancer Agents Med Chem; 2015; 15(4):461-7. PubMed ID: 25553438
[TBL] [Abstract][Full Text] [Related]
17. Single versus combination immunotherapy drug treatment in melanoma.
Grimaldi AM; Marincola FM; Ascierto PA
Expert Opin Biol Ther; 2016; 16(4):433-41. PubMed ID: 26642234
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging systemic therapies for cutaneous metastatic melanoma.
Mason R; Au L; Ingles Garces A; Larkin J
Expert Opin Pharmacother; 2019 Jun; 20(9):1135-1152. PubMed ID: 31025594
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in melanoma: Recent advances and future directions.
Franklin C; Livingstone E; Roesch A; Schilling B; Schadendorf D
Eur J Surg Oncol; 2017 Mar; 43(3):604-611. PubMed ID: 27769635
[TBL] [Abstract][Full Text] [Related]
20. The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.
Pennock GK; Chow LQ
Oncologist; 2015 Jul; 20(7):812-22. PubMed ID: 26069281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]